Perioperative immunotherapy improves event-free survival in resectable early-stage lung cancer

  • Post author:
  • Post category:uncategorized

Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer…

Continue ReadingPerioperative immunotherapy improves event-free survival in resectable early-stage lung cancer